Pharmaceutical Technology

NOVEMBER 28, 2022

Under the agreement, AstraZeneca will be responsible for the development and marketing of oral therapy for inflammatory and respiratory diseases with a key focus on chronic obstructive pulmonary disease (COPD). This includes an upfront payment of $2m from AstraZeneca. Additionally, AstraZeneca will make a potential payment of $385.8m

Pharmaceutical 105

Pharmaceutical Marketing Leads 105

pharmaphorum

NOVEMBER 14, 2022

Sanofi and Regeneron are running a phase 3 trial of the drug in COPD patients with type 2 inflammation called NOTUS that is due to generate results next year. Sanofi and Regeneron have predicted that Dupixent could make around $13 billion a year at peak, which would propel the drug into the top five biggest pharmaceutical sellers.

Sales 95

Sales Medicine Patients Leads 95

Pharmaceutical Technology

SEPTEMBER 5, 2022

An example of AstraZeneca’s deals in the cardiovascular disease clinical landscape is its agreement with US-based Dogma Therapeutics. In 2021, AstraZeneca sold $270 million worth of assets to Covis Pharma, which then transferred AstraZeneca’s chronic obstructive pulmonary disease (COPD) inhalers Tudorza and Duaklir to Covis.

FDA 114

FDA Pharmaceutical Biopharma Pharma 114

pharmaphorum

DECEMBER 19, 2022

It would provide an alternative to standard breathing exercises for patients with conditions that affect breathing, including long-term respiratory diseases like asthma, chronic obstructive pulmonary disorder (COPD) and cystic fibrosis, which can be resource-intensive as they require patients to be overseen by a healthcare worker.

Patients 138

Patients Engineering Government Education 138

pharmaphorum

OCTOBER 26, 2022

Boehringer Ingelheim has moved one of its top pipeline prospects – oral phosphodiesterase 4B (PDE4B) inhibitor BI 1015550 – into late-stage clinical testing for idiopathic pulmonary fibrosis and other interstitial lung diseases (ILDs). ” The post Seeking Ofev successor, Boehringer takes PDE4B drug into phase 3 appeared first on.

Recruitment 90

Recruitment Prospecting Marketing Patients 90

pharmaphorum

JANUARY 17, 2023

Unify, launched in December 2020, is AstraZeneca’s patient app and clinical trial support tool. Attrition in drug development for chronic disease is high, often because the wrong patients are selected for clinical trials,” Challis explained. Digital technology and ‘frictionless’ clinical trials. Dissecting heterogeneity.

Medicine 97

Medicine Patients Transportation Healthcare 97

Pharmaceutical Technology

APRIL 26, 2023

Dr. Amy Chan, senior clinical research fellow at the School of Pharmacy, University of Auckland, says digital inhalers have existed for almost 30 years. In a 2020 study, Chan found devices that can easily calculate adherence to activation and inhalation could have the greatest utility in clinical practice.

Electronics 115

Electronics Medical Patients Healthcare 115

Legacy MEDSearch

SEPTEMBER 7, 2023

Anil Kukreja, VP of Medical Affairs and Regulatory at AstraZeneca Pharma India, praised the FDA clearance as a milestone, highlighting alveofit’s role in optimized diagnosis and management of lung disorders such as asthma and COPD. Earlier this year, to cater to the growing U.S. market, alveofit® inaugurated its office in New York.

FDA 52

FDA Recruitment Distribution Healthcare 52

pharmaphorum

JULY 28, 2022

The drug is also being tested in some forms of chronic obstructive pulmonary disease (COPD), and various conditions leading to urticaria (hives), although it fell short in a phase 3 trial in chronic spontaneous urticaria (CSU) earlier this year. The post Dupixent drives Sanofi to hike its full-year profit forecasts appeared first on.

Sales 59

Sales FDA Medicine Leads 59

PM360

DECEMBER 14, 2023

MedCentral aims to close the information gaps for physicians treating patients with complex, chronic conditions including diabetes, COPD, and a range of autoimmune-mediated conditions with deeply researched content compiled by an experienced editorial staff.

Physicians 52

Physicians Pharma Medical Patients 52

PM360

SEPTEMBER 21, 2023

Jeff Casberg, MS, RPh, Senior Vice President of Clinical Pharmacy at IPD Analytics, a managed care and pharmaceutical consultancy, highlighted a wide range of 2023 key events that will affect managed care professionals by the end of the year. This one is expected to have nine generic competitors this year, Casberg said.

Management 105

Management Manufacturing Sales Competition 105

Legacy MEDSearch

JULY 18, 2023

“ReddyPort’s patented elbow is central to the eco-system we are building to help mitigate clinical obstacles tied to NIV therapy from dry-mouth, oral biofilm accumulation to speech recognition,” says Tony Lair, ReddyPort CEO. 7 In addition, NIV is utilized to wean patients off mechanical ventilation.

FDA 52

FDA Food and Drug Administration Recruitment Patients 52

pharmaphorum

JANUARY 12, 2023

Avillion – clinical co-development partner with AZ – conducted the global phase 3 trial of over 4,000 patients across four studies (including the MANDALA and DENALI trials). The new approval continues the company’s unmarred success rate in clinical co-development partnerships across multiple therapeutic areas.

FDA 52

FDA Food and Drug Administration Medical Patients 52

pharmaphorum

JULY 21, 2022

Gefapixant is already approved in Japan as Lyfnua, but Bayer and Bellus are in hot pursuit of the drug in the US with their respective eliapixant and BLU-5937 candidates, which are both in late-stage clinical testing. The post After cough drug setback, Merck partners Hyfe’s tracking app appeared first on.

FDA 52

FDA Education Medical Patients 52

PM360

JUNE 11, 2022

So, how many life sciences companies are actually making an effort to include patients in things like drug development strategies, clinical trial protocols, patient engagement communication, etc.? 6%: Including patient authors, peer-reviewers, guest editors, and contributors to journals for clinical trial publications.

Patients 98

Patients Medical Education Government 98

Clarivate

OCTOBER 11, 2021

At this point, we did not know the whole clinical profile. Special populations of interest included patients with autoimmune diseases/co-infected with other viruses, and those with asthma or COPD. “The limiting factor of this collaboration was that we had very little time,” she says. Italy was being very badly hit.

Distribution 98

Distribution Medical Specialization Training 98

pharmaphorum

JANUARY 27, 2023

An additional note of optimism is that UK biotechs achieved pivotal milestones in their development, with Verona Pharma reporting a successful phase 3 trial for Ensifentrine, the first novel compound in over 10 years to address the ongoing needs of more than 380 million patients worldwide suffering from Chronic Obstructive Pulmonary Disease (COPD).

Pharma 52

Pharma Manufacturing Biopharma Medicine 52

Pharmaceutical Technology

JULY 18, 2022

These include the ongoing clinical development of AstraZeneca’s Fasenra (benralizumab), Insmed’s brensocatib and Novartis’ icenticaftor (QBW251). As such, the opportunity remains for developers to continue to conduct clinical research in this area, with the hopes of more MOAs to enter the space in the future.

Marketing 59

Marketing Safety Management Patients 59

pharmaphorum

DECEMBER 15, 2022

6 RSV can exacerbate the symptoms of asthma and chronic obstructive pulmonary disease (COPD). Due to the similar nature of RSV’s symptoms compared to other respiratory diseases, the only way to definitively diagnose the virus is through clinical testing. Mayo Clinic. Cleveland Clinic. Respiratory Syncytial Virus.

Leads 69

Leads Medical Management Patients 69

pharmaphorum

AUGUST 8, 2022

Multiple therapy areas are covered, including heart failure, chronic kidney disease, renal cell carcinoma, CAR-T and multiple myeloma, lung cancer, fibrodysplasia ossificans, progressive (FOP), atopic dermatitis, COPD, severe asthma, lupus, ulcerative colitis, biologic injectables, and, most recently, type 2 diabetes.

Patients 52

Patients Healthcare Healthcare Pharma 52

PM360

JULY 13, 2023

Second, a patient may be on the right regimen, in which their five or more drugs are prescribed based on clinical evidence. 15 Pharmacists are true experts in the clinical use of medications and see patients with chronic conditions up to 10 times more per year than their physicians do. different doctors during their lives.

Prescription 52

Prescription Medical Physicians Education 52

pharmaphorum

NOVEMBER 28, 2022

The deal will enable AZ to develop and commercialise an oral therapy for the treatment of inflammatory and respiratory diseases, with a lead focus on chronic obstructive pulmonary disease (COPD). COPD is the third leading cause of death worldwide, with 3.23 Smoking is a major cause of COPD. million deaths in 2019 alone.

Leads 52

Leads Pharma Marketing 52

European Pharmaceutical Review

DECEMBER 20, 2022

The ambition is to use technological and digital solutions to reduce the burden for patients and trialists, so that clinical trial participation ultimately becomes part of daily practice” In a typical year, AstraZeneca conducts over 240 global clinical trials , involving more than 123,000 patients in around 60 countries.

Medicine 98

Medicine Recruitment Consulting Patients 98

European Pharmaceutical Review

JULY 19, 2022

Transpire Bio and Recipharm have signed a definitive agreement for the development of TRB-1 and TRB-2 – two inhaled medicines for the treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD). COPD was the third-leading cause of death in 2019, with approximately 3.2 million lives lost. About Transpire Bio.

Medicine 98

Medicine Manufacturing Pharmaceutical products Pharmaceutical 98

European Pharmaceutical Review

MAY 4, 2023

Clinical evidence that led to the FDA’s landmark approval The safety and effectiveness of Arexvy is based on the FDA’s analysis of data from an ongoing, randomised, placebo-controlled clinical study in individuals 60 years of age and older. Now, the FDA has granted this milestone to GSK’s Arexvy.

Food and Drug Administration 88

Food and Drug Administration Safety FDA Food 88

pharmaphorum

JULY 7, 2022

For years, diagnosis of OSA has relied on complex polysomnography equipment to monitor heart, lung and brain activity, breathing patterns, limb movements, and blood oxygen levels while the patient sleeps, so is generally carried out in a clinic.

FDA 103

FDA Prescription Healthcare Provider Physicians 103

Evolve Your Success

MAY 16, 2023

In his medical startup, he addresses the need for substance abuse mitigation in South Carolina using a unique approach where patients can come just like they’re going to a doctor’s clinic. They started our first clinic in Greer, South Carolina, which is a little East of Greenville. It’s where the giant BMW plant is.

Medical sales 52

Medical sales Sales Medical Doctors 52

Clarify Health

NOVEMBER 8, 2023

And so we also think about balancing that access with meeting providers, clinical social convenience needs. As I mentioned earlier, so the clinical monitoring is ongoing with daily huddles with our nurses. So that is reviewed in a daily huddle of nurses and clinical leadership. We also care about access in our broad network.

Networking 52

Networking Management Patients Physicians 52

PM360

JUNE 11, 2022

For example, consider a pharma brand team trying to market its newest triple inhaler therapy for the treatment of COPD against its top competitor. It also faced negative press when The Lancet published an editorial condemning the quality of its clinical trials. history.

Marketing 52

Marketing Competition Pharma Manufacturing 52

Pharma Marketing Network

OCTOBER 27, 2020

So what I’d like to do is start off talking a little bit about your professional speaking on the shifts and Healthcare delivery from clinics into the homes of patients and caregivers. First it has a black box warning it’s contraindicated in things like COPD and asthma because powdered aerosols make you cough is a big problem.

Education 52

Education Marketing Healthcare Healthcare 52

Pharma Marketing Network

OCTOBER 27, 2020

So what I’d like to do is start off talking a little bit about your professional speaking on the shifts and Healthcare delivery from clinics into the homes of patients and caregivers. First it has a black box warning it’s contraindicated in things like COPD and asthma because powdered aerosols make you cough is a big problem.

Education 52

Education Healthcare Healthcare Doctors 52

PM360

NOVEMBER 21, 2022

Recently, clinics and psychiatrists have been receptive to FDA approved Spravato , or esketamine, which is chemically related to ketamine and administered in clinics for treatment-resistant depression. Medable Simplifies Consent Management for Clinical Trials. Medable Simplifies Consent Management for Clinical Trials.

Government 52

Government Prescription FDA Patients 52